The Role of Intranasal Corticosteroids in the Management of Chronic Idiopathic Urticaria with Positive Skin Prick Test to Airborne Allergens
- Conditions
- Chronic Idiopathic Urticaria.Idiopathic urticariaL50.1
- Registration Number
- IRCT20231126060193N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 69
Inclusion Criteria:Patients must be older than eighteen years.Patients must have a diagnosis of idiopathic urticaria and positive prick test results for airborne antigens.Patients should be selected from adult allergy clinics.Patients must give their informed consent to participate in the study.
Patients who are under treatment other than antihistamines by a doctor specializing in asthma and allergies.Patients who cannot participate during six months.Patients who had serious side effects due to corticosteroids before the start of the study.Patients who have serious side effects caused by the use of corticosteroids during the study period.Patients who experience serious side effects from corticosteroids during the study period.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome measures include the frequency and severity of urticaria symptoms, which are evaluated using valid scoring systems such as the Urticaria Activity Score and the Urticaria Severity Score. Timepoint: At the beginning of the study (before the start of the intervention) and six months after the start of the study. Method of measurement: Quality of life questionnaire related to chronic urticaria.
- Secondary Outcome Measures
Name Time Method